A recent study indicated that MEG3 promoted β-catenin degradation via GSK-3β, which in turn inactivated the Wnt pathway and ultimately inhibited the invasion and metastasis of retinoblastoma cells [56]. This evidence concerns the gene MEG3 and retinoblastoma.